Alpine Immune Sciences Inc (ALPN)
64.60
0.00 (0.00%)
USD |
NASDAQ |
May 02, 11:34
Alpine Immune Sciences Total Long Term Debt (Quarterly): 0.00 for Dec. 31, 2023
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.00 |
September 30, 2023 | 0.00 |
June 30, 2023 | 0.00 |
March 31, 2023 | 2.206M |
December 31, 2022 | 3.38M |
September 30, 2022 | 4.547M |
June 30, 2022 | 5.707M |
March 31, 2022 | 6.858M |
December 31, 2021 | 8.002M |
September 30, 2021 | 9.141M |
June 30, 2021 | 10.27M |
March 31, 2021 | 10.20M |
December 31, 2020 | 10.13M |
Date | Value |
---|---|
September 30, 2020 | 10.06M |
June 30, 2020 | 9.992M |
March 31, 2020 | 9.911M |
December 31, 2019 | 4.927M |
September 30, 2019 | 4.886M |
June 30, 2019 | 3.27M |
March 31, 2019 | 3.738M |
December 31, 2018 | 4.203M |
September 30, 2018 | 4.665M |
June 30, 2018 | 5.122M |
March 31, 2018 | 5.078M |
December 31, 2017 | 5.034M |
September 30, 2017 | 4.99M |
Total Long Term Debt Definition
Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2023
10.27M
Maximum
Jun 2021
5.973M
Average
5.707M
Median
Jun 2022
Total Long Term Debt (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 0.00 |
Eliem Therapeutics Inc | -- |
Regeneron Pharmaceuticals Inc | 1.983B |
Vera Therapeutics Inc | -- |
Eyenovia Inc | 14.29M |